The Cancer Genomics Consortium (CGC) is a non-profit organization formed in August, 2009 by a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in applying microarray technologies to cancer diagnosis and cancer research.
Since its inception, the CGC has hosted seven annual meetings bringing together the clinical genomics community to educate for best practices. This has led to numerous collaborations including the first CGC-sponsored multicenter cross-platform cytogenomic microarray study, published in Cancer Genetics in 2015.
Today, the CGC has grown to include more than 300 members from over 150 organizations in the U.S., Canada, and abroad. We encourage all members to actively participate in CGC activities and welcome comments and suggestions. Working together, we are confident that we can achieve our goals.